Company news
Avenir Wellness Solutions Inc. news in 2021
Avenir Wellness Solutions Inc.'s news releases, calls and decks from 2021, newest first.
Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor
December 9, 2021
CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology
November 16, 2021
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
August 17, 2021
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 15, 2021
Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains
August 4, 2021
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
June 15, 2021
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
June 10, 2021
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign
June 9, 2021
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
May 25, 2021
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
May 17, 2021
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility
May 13, 2021
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021 and Talk the Future of Beauty Technology
April 28, 2021
CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
April 21, 2021
CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT
April 19, 2021
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021
April 13, 2021
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020
April 1, 2021
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
March 23, 2021
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders
March 16, 2021
CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications
March 10, 2021
CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.
March 3, 2021
CURE Pharmaceutical Announces the Initiation of Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
February 23, 2021
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
February 11, 2021
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
February 10, 2021
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
February 2, 2021
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
January 19, 2021
CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
January 7, 2021
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
January 5, 2021